Wockhardt LimitedNSE: WOCKPHARMA

Press Release Aug 16 2022

· Issued by Wockhardt Limited

Wockhardt Limited has informed the Exchange about press release dated 16-Aug-2022 titled Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222

View Attachment